Cargando…

Adiponectin and Its Receptors in Chronic Hepatitis B Patients With Steatosis in China

BACKGROUND: HBV infection is a serious public health problem worldwide, which can contribute to the incidence of chronic hepatitis B (CHB), cirrhosis, and hepatocellular carcinoma (HCC). OBJECTIVES: In the present report, we assessed the association between adiponectin, its receptors and hepatic ste...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Di, Li, Hongqi, Xiang, Guoan, Zhang, Liwei, Li, Lihong, Cao, Yongmei, Zhang, Jinqian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3725260/ https://www.ncbi.nlm.nih.gov/pubmed/23914225 http://dx.doi.org/10.5812/hepatmon.6065

Ejemplares similares

Associations of circulating chemerin and adiponectin concentrations with hepatic steatosis
por: Levin, Lena-Maria, et al.
Publicado: (2019)

The N-Glycosylation Modification of LHBs (Large Surface Proteins of HBV) Effects on Endoplasmic Reticulum Stress, Cell Proliferation and its Secretion
por: Liu, Wenxiang, et al.
Publicado: (2013)

[Retracted] FAM172A induces S phase arrest of HepG2 cells via Notch 3
por: Feng, Zhiqiang, et al.
Publicado: (2023)

Upregulation of adiponectin by Ginsenoside Rb1 contributes to amelioration of hepatic steatosis induced by high fat diet
por: Li, Yaru, et al.
Publicado: (2022)

Fucoidan and Fucoxanthin Attenuate Hepatic Steatosis and Inflammation of NAFLD through Modulation of Leptin/Adiponectin Axis
por: Shih, Ping-Hsiao, et al.
Publicado: (2021)

Single-wall carbon nanohorns inhibited activation of microglia induced by lipopolysaccharide through blocking of Sirt3
por: Li, Lihong, et al.
Publicado: (2013)

Retraction Note: Single-wall carbon nanohorns inhibited activation of microglia induced by lipopolysaccharide through blocking of Sirt3
por: Li, Lihong, et al.
Publicado: (2023)

Prevention of Nonalcoholic Hepatic Steatosis by Shenling Baizhu Powder: Involvement of Adiponectin-Induced Inhibition of Hepatic SREBP-1c
por: Tang, Kairui, et al.
Publicado: (2020)

Association of adiponectin with hepatic steatosis: a study of 1,349 subjects in a random population sample
por: Flechtner-Mors, Marion, et al.
Publicado: (2014)

BuShenKangShuai Tablet Alleviates Hepatic Steatosis via Improving Liver Adiponectin Resistance in ApoE(−/−) Mice
por: Pang, Shu-chao, et al.
Publicado: (2019)

Saroglitazar improved hepatic steatosis and fibrosis by modulating inflammatory cytokines and adiponectin in an animal model of non-alcoholic steatohepatitis
por: Akbari, Rasoul, et al.
Publicado: (2021)

The Nuclear Orphan Receptor NR2F6 Promotes Hepatic Steatosis through Upregulation of Fatty Acid Transporter CD36
por: Zhou, Bing, et al.
Publicado: (2020)

Morphometric Analysis of Hepatic Steatosis in Chronic Hepatitis C Infection
por: Zubair, Alia, et al.
Publicado: (2009)

Role of Adiponectin and Its Receptors in Cancer
por: Obeid, Stephanie, et al.
Publicado: (2012)

Role of glycoprotein 78 and cidec in hepatic steatosis
por: Li, Jie, et al.
Publicado: (2017)

Adiponectin receptor agonist AdipoRon relieves endotoxin-induced acute hepatitis in mice
por: Xiao, Wen-Ze, et al.
Publicado: (2019)

Computed Tomography Measurement of Hepatic Steatosis: Prevalence of Hepatic Steatosis in a Canadian Population
por: Wells, Malcolm M., et al.
Publicado: (2016)

Association between SII and hepatic steatosis and liver fibrosis: A population-based study
por: Xie, Ruijie, et al.
Publicado: (2022)

Aquaporin-8 ameliorates hepatic steatosis through farnesoid X receptor in obese mice
por: Xiang, Minqi, et al.
Publicado: (2023)

Aquaporin-8 ameliorates hepatic steatosis through farnesoid X receptor in obese mice
por: Xiang, Minqi, et al.
Publicado: (2023)

Hepatic Steatosis and Fibrosis in Chronic Inflammatory Bowel Disease
por: Veltkamp, Claudia, et al.
Publicado: (2022)

Clinical and Virological Characteristics of Chronic Hepatitis B Patients with Hepatic Steatosis
por: Zheng, Rui-dan, et al.
Publicado: (2013)

Diagnostic and prognostic significance of hepatic steatosis in patients with chronic hepatitis C
por: Stan, Ionelia Sorina, et al.
Publicado: (2021)

Effects of interventions on adiponectin and adiponectin receptors
por: Lee, Sewon, et al.
Publicado: (2014)

Adiponectin/adiponectin receptor in disease and aging
por: Iwabu, Masato, et al.
Publicado: (2015)

Hepatic Fibrosis and Steatosis in Metabolic Syndrome
por: Gangireddy, Venu Gopala Reddy, et al.
Publicado: (2022)

Steatosis and hepatitis C
por: Modaresi Esfeh, Jamak, et al.
Publicado: (2016)

Cancer and hepatic steatosis
por: Paternostro, R., et al.
Publicado: (2021)

Prevalence of hepatic steatosis and associated factors in Iranian patients with chronic hepatitis C
por: Poortahmasebi, Vahdat, et al.
Publicado: (2016)

How does hepatic steatosis affect the outcome of patients with chronic hepatitis B?
por: Yu, Jung Hwan, et al.
Publicado: (2019)

Chronic hepatitis B infection with concomitant hepatic steatosis: Current evidence and opinion
por: Shi, Yi-Wen, et al.
Publicado: (2021)

MicroRNA-449 suppresses proliferation of hepatoma cell lines through blockade lipid metabolic pathway related to SIRT1
por: Zhang, Hongyi, et al.
Publicado: (2023)

Adiponectin Increases Secretion of Rat Submandibular Gland via Adiponectin Receptors-Mediated AMPK Signaling
por: Ding, Chong, et al.
Publicado: (2013)

Risk factors for acute hepatitis B and its progression to chronic hepatitis in Shanghai, China
por: Zhang, H W, et al.
Publicado: (2008)

Lack of adiponectin and adiponectin receptor 1 contributes to benign prostatic hyperplasia
por: Fu, Shi, et al.
Publicado: (2017)

Effect of silibinin capsules combined with lifestyle modification on hepatic steatosis in patients with chronic hepatitis B
por: Lv, Duo-Duo, et al.
Publicado: (2021)

Association between Hepatic Steatosis and Entecavir Treatment Failure in Chinese Patients with Chronic Hepatitis B
por: Jin, Xi, et al.
Publicado: (2012)

Effect of hepatic steatosis on the progression of chronic hepatitis B: A prospective cohort and in vitro study
por: Chen, Yangqin, et al.
Publicado: (2017)

Concurrence and impact of hepatic steatosis on chronic hepatitis B patients: a systematic review and meta-analysis
por: Jiang, Daixi, et al.
Publicado: (2021)

JMJD4-demethylated RIG-I prevents hepatic steatosis and carcinogenesis
por: Li, Zhenyang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_matc8ko0kg6r8rc48a3nmpdjjs